R&D | June 01, 2026
International scientists say deuterium research could reshape medicine
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The study tracked patients for more than five years (median 60.7 months), with protection against disease returning emerging in under four months and continuing long term
The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments
As per National Health Accounts (NHA) estimates, government health expenditure rose steadily between 2013-14 and 2022-23, while out-of-pocket spending declined significantly
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
A one-shot gene-editing cholesterol therapy could soon be a reality
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
The competition received over 42 entries from nursing colleges across Maharashtra
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
